Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06703060 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women

Study acronym: MATCH
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 24, 2025 to Feb 28, 2025
    • Site details revised
    v4
  3. Start date: Jan 2025 to Feb 24, 2025v3
  4. Start date: Nov 2024 to Jan 2025v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
U.S. epidemiological data indicates that Black women are a high-risk HIV disparity group, yet initiation of novel prevention strategies like pre-exposure prophylaxis (PrEP) among this group is stagnant. Socio-structural challenges like intimate partner violence and gendered racism can constrain PrEP access among Black women, but few implementation studies have mitigated these challenges to improve PrEP initiation. The proposed research aims to implement and assess the effectiveness, implementation, and sustainability of a multilevel intervention to increase PrEP initiation among Black women with and without intimate partner violence in Baltimore.
Trial Details
NCT Number NCT06703060
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 HIV Prevention, PrEP, Women, Intimate Partner Violence (IPV)
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov